If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mark Stein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Androgens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

8 Citations (Scopus)

A phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: Efficacy and biomarkers

Beltran, H., Oromendia, C., Danila, D. C., Montgomery, B., Hoimes, C., Szmulewitz, R. Z., Vaishampayan, U., Armstrong, A. J., Stein, M., Pinski, J., Mosquera, J. M., Sailer, V., Bareja, R., Romanel, A., Gumpeni, N., Sboner, A., Dardenne, E., Puca, L., Prandi, D., Rubin, M. A. & 6 others, Scher, H. I., Rickman, D. S., Demichelis, F., Nanus, D. M., Ballman, K. V. & Tagawa, S. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 43-51 9 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Aurora Kinases
Castration
Tumor Biomarkers
Prostatic Neoplasms
Organoids

A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

Stein, M., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.

Rutgers, The State University

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Neoplasms
Area Under Curve
Prostate

A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors

Mehnert, J., Kaveney, A. D., Malhotra, J., Spencer, K., Portal, D., Goodin, S., Tan, A. R., Aisner, J., Moss, R. A., Lin, H., Bertino, J., Gibbon, D., Doyle, L. A., White, E. & Stein, M., Jan 1 2019, (Accepted/In press) In : Cancer chemotherapy and pharmacology.

Rutgers, The State University

Research output: Contribution to journalArticle

Hydroxychloroquine
Tumors
Neoplasms
Exanthema
Fatigue
5 Citations (Scopus)

Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma

Haas, N. B., Appleman, L. J., Stein, M., Redlinger, M., Wilks, M., Xu, X., Onorati, A., Kalavacharla, A., Kim, T., Zhen, C. J., Kadri, S., Segal, J. P., Gimotty, P. A., Davis, L. E. & Amaravadi, R. K., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2080-2087 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Hydroxychloroquine
Autophagy
Renal Cell Carcinoma
Disease-Free Survival
Everolimus

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Ferrari, A., Alumkal, J. J., Stein, M., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. M., Apr 15 2019, In : Clinical Cancer Research. 25, 8, 1 p.

Rutgers, The State University

Research output: Contribution to journalComment/debate

Open Access
Castration
Epigenomics
Prostatic Neoplasms
Emotions
Research